Easom Eric
Insider CIK 1914503 · ANTX Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 249,999 | — | $0 | 249,999 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 267,650 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 249,999 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 225,000 | — | $0 | 225,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 225,000 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 267,650 | — | $0 | 267,650 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-02-20 | 2026-02-23 | 224,500 | — | $0 | 224,500 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2026-02-20 | 2026-02-23 | 112,250 | — | $0 | 368,630 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | P Buy | 2025-06-02 | 2025-06-03 | 10,000 | $1.07 | $10.7K | 256,380 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2025-02-26 | 2025-02-28 | 290,500 | — | $0 | 290,500 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2025-02-26 | 2025-02-28 | 145,250 | — | $0 | 246,380 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | P Buy | 2024-11-18 | 2024-11-18 | 50,000 | $1.00 | $50.0K | 1,065,766 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2024-03-15 | 2024-03-18 | 198,000 | — | $0 | 198,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2024-03-15 | 2024-03-18 | 99,000 | — | $0 | 101,130 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2024-03-15 | 2024-03-29 | 99,000 | — | $0 | 101,130 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 2,777 | $20.09 | $55.8K | 2,130 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | P Buy | 2023-05-15 | 2023-05-15 | 10,000 | $5.38 | $53.8K | 1,015,766 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2023-02-23 | 2023-02-24 | 267,650 | — | $0 | 267,650 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-11-14 | 2022-11-14 | 23 | $15.04 | $346 | 4,907 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-11-10 | 2022-11-14 | 4,413 | $15.32 | $67.6K | 4,930 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-11-09 | 2022-11-09 | 10,111 | $15.61 | $157.8K | 4,907 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-11-08 | 2022-11-09 | 5,800 | $15.41 | $89.4K | 16,273 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-11-08 | 2022-11-09 | 1,255 | $16.38 | $20.6K | 15,018 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-11-07 | 2022-11-07 | 10,167 | $15.90 | $161.7K | 6,943 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-11-07 | 2022-11-07 | 2,036 | $16.72 | $34.0K | 4,907 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-11-04 | 2022-11-07 | 8,828 | $15.80 | $139.5K | 17,110 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-11-03 | 2022-11-07 | 3,083 | $16.02 | $49.4K | 25,938 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-11-03 | 2022-11-07 | 11,082 | $15.67 | $173.7K | 29,021 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-11-02 | 2022-11-02 | 1,544 | $15.07 | $23.3K | 4,907 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-02 | 2,688 | $15.39 | $41.4K | 6,451 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-10-28 | 2022-10-28 | 1,683 | $15.09 | $25.4K | 4,907 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-10-27 | 2022-10-28 | 924 | $15.36 | $14.2K | 6,590 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-10-26 | 2022-10-26 | 1,678 | $15.10 | $25.3K | 4,907 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-10-25 | 2022-10-26 | 4,272 | $15.69 | $67.0K | 7,119 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-10-25 | 2022-10-26 | 534 | $16.20 | $8.7K | 6,585 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-10-24 | 2022-10-26 | 2,866 | $16.17 | $46.3K | 11,391 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-10-21 | 2022-10-24 | 11,601 | $16.29 | $189.0K | 7,257 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-10-21 | 2022-10-24 | 2,350 | $16.69 | $39.2K | 4,907 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-10-20 | 2022-10-24 | 31 | $17.15 | $532 | 18,858 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2022-10-20 | 2022-10-24 | 7,262 | $16.68 | $121.1K | 18,889 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2022-05-12 | 2022-05-16 | 225,000 | — | $0 | 225,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | C Conversion deriv | 2022-03-29 | 2022-03-31 | 4,907 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | C Conversion | 2022-03-29 | 2022-03-31 | 4,907 | — | $0 | 4,907 | SEC↗ |